Hormone therapy for prostate cancer works on a straightforward principle: prostate cancer cells often depend on testosterone to grow. Hormone therapy either lowers the amount of testosterone in the body or stops cancer cells from using it. This approach doesn't destroy cancer cells the way chemotherapy does, but instead slows or stops their growth.
Learn About Paying Your FGUA Bill Online →
The medical term for hormone therapy in prostate cancer is androgen deprivation therapy, or ADT. "Androgen" refers to male hormones like testosterone. When doctors recommend ADT, they're aiming to deprive cancer cells of the fuel they need to multiply. Think of it like removing the gas from a car's engine—the car doesn't disappear, but it stops running.
There are several ways doctors achieve this hormone reduction. Some medications block the body's production of testosterone. Others work like a lock and key: they prevent cancer cells from recognizing or using testosterone that's already present. Some treatments do both. The specific method depends on the stage of cancer, the patient's overall health, and what other treatments are being used alongside hormone therapy.
Hormone therapy isn't always a permanent treatment. Depending on the cancer stage and type, it might be used for a few months, several years, or indefinitely. Early-stage prostate cancers might need only short-term hormone therapy combined with radiation. More advanced cancers often require longer treatment periods. Some patients eventually develop resistance to hormone therapy, meaning their cancer cells learn to grow even with low testosterone levels.
Practical takeaway: Understanding that hormone therapy works by removing testosterone's role in cancer growth helps explain why side effects tend to relate to low testosterone levels—information covered later in this guide.
Doctors can prescribe different categories of hormone-blocking medications, and each works through a distinct mechanism. Knowing the differences helps patients understand their treatment plan and what to expect.
Free Guide to Pay by Plate Illinois Billing →
GnRH agonists are among the most commonly prescribed. These medications include leuprolide (Lupron), goserelin (Zoladex), and triptorelin (Trelstar). They work by sending a signal to the pituitary gland—a small gland at the base of the brain that controls hormone production. Initially, GnRH agonists stimulate testosterone production, but with continued use, they actually shut down this production. Patients receive injections either monthly, every three months, or every six months, depending on the formulation.
GnRH antagonists are a newer category that includes degarelix (Firmagon). Unlike agonists, antagonists immediately block testosterone production without the initial surge. This matters for some patients whose cancer might be affected by sudden testosterone spikes. These require monthly injections.
Androgen receptor blockers or anti-androgens work differently. Instead of lowering testosterone, they prevent cancer cells from using testosterone that's present. Common medications in this category include bicalutamide (Casodex), enzalutamide (Xtandi), and apalutamide (ARN-509). These are typically pills taken daily. Sometimes doctors prescribe these alongside GnRH agonists—a combination called combined androgen blockade—to attack cancer from two angles.
CYP17 inhibitors like abiraterone (Zytiga) are pills that block an enzyme involved in testosterone production. They're often used for advanced cancers that have resisted initial hormone therapy. These typically require multiple doses daily.
The choice between these categories depends on cancer stage, prior treatments, side effect tolerance, and patient preference regarding injection frequency versus daily pills. Some patients stay on one medication; others switch between types if their cancer becomes resistant.
Practical takeaway: Hormone therapy medications come in different forms (injections vs. pills) and work through different mechanisms—this affects both how often treatment occurs and which side effects a patient might experience.
Because hormone therapy lowers testosterone throughout the body, not just around cancer cells, patients experience side effects related to low testosterone levels. Understanding these ahead of time helps people recognize what's happening and plan accordingly.
Free Guide to Mold Removal Methods for Walls →
Hot flashes rank among the most common and bothersome side effects. Studies show that 50 to 80 percent of men on hormone therapy experience them. These feel similar to the hot flashes women experience during menopause—sudden waves of heat, sweating, and flushing that can last from seconds to several minutes. They're usually worse at night and can disrupt sleep for weeks or months into treatment. There's no way to predict if someone will get them, how severe they'll be, or how long they'll last. Some patients' hot flashes fade over time; others persist throughout treatment.
Weight gain and loss of muscle mass occur in most patients on long-term hormone therapy. Testosterone normally helps build and maintain muscle. Without it, muscle gradually weakens and converts to fat, typically resulting in 5 to 15 pound weight gains over months. This isn't about eating more—it's a metabolic shift. The combination of fat gain and muscle loss creates a double impact on body composition and strength.
Bone density decreases during hormone therapy, similar to osteoporosis. Studies show that men can lose 2 to 5 percent of bone mass annually while on ADT. This happens because testosterone supports bone strength. Longer treatment duration increases this risk. This isn't usually noticeable day-to-day, but it raises the risk of fractures from falls or minor injuries.
Sexual function changes are common. Many men experience erectile dysfunction or complete loss of interest in sex. This is a direct effect of testosterone loss. Notably, it can continue after hormone therapy ends—sometimes permanently. Some patients report these changes affect their relationships and self-image significantly.
Other documented side effects include breast tissue growth and tenderness, fatigue, headaches, nausea, and diarrhea. Less common but serious effects include liver problems (with certain medications), elevated blood sugar, and increased cardiovascular risk with prolonged use.
Practical takeaway: Side effects from hormone therapy are real and warrant serious planning—from managing hot flashes to maintaining muscle through exercise to discussing sexual changes with partners and doctors.
While doctors cannot eliminate side effects entirely, multiple strategies can reduce their impact on daily life. These aren't theoretical—many come from what patients report actually works.
How to Delete Your Fitbit Account Guide →
For hot flashes, behavioral approaches help some patients. Dressing in layers, keeping rooms cool, drinking cold water, and avoiding hot beverages or spicy foods may reduce frequency or intensity. Some patients find relief with venlafaxine (Effexor), a low-dose antidepressant that reduces hot flashes by about 60 percent in clinical trials. Gabapentin (Neurontin) shows similar benefits for some patients. Neither requires waiting weeks for effect—both can show improvement within days.
Managing weight gain requires attention to two areas: exercise and diet. Weight training, specifically, helps preserve muscle mass that hormone therapy would otherwise take. Research shows that men doing resistance training 2 to 3 times weekly maintain significantly more muscle than sedentary counterparts. Cardiovascular exercise protects heart health. A diet focusing on lean proteins, whole grains, and vegetables helps prevent excess fat gain. Many patients work with nutritionists to adjust eating patterns as their metabolism shifts.
Bone health requires proactive measures for patients on long-term hormone therapy. Weight-bearing exercise (walking, jogging, stair climbing) stimulates bone formation. Adequate calcium intake—through dairy, leafy greens, or supplements—provides building blocks for bone. Vitamin D helps the body absorb calcium. Some patients, particularly those with known risk factors or years of planned ADT, take bone-strengthening medications like bisphosphonates or denosumab. Doctors can measure bone density with a DEXA scan to determine individual risk and whether medication is warranted.
Sexual function changes merit open conversation with partners and doctors. Some men benefit from erectile dysfunction medications like sildenafil (Viagra) or tadalafil (Cialis). Others find counseling helps address psychological components. Being honest about these changes reduces isolation and allows partners to understand what's happening.
Fatigue management involves balancing activity with rest. Gentle exercise
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.